Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clover Corporation Limited ( (AU:CLV) ) just unveiled an announcement.
Clover Corporation Limited has moved to reassure the market that its products are not implicated in recent infant formula recalls linked to contamination in a batch of ARA (Arachidonic Acid) oil supplied by an unrelated third party. The company said routine quality controls and additional targeted testing confirm its products remain safe, fully compliant and unaffected, and stressed it has no sourcing, supply, commercial or technical ties to the supplier involved. Clover remains fully operational with uninterrupted supply, and is actively working with customers on alternative formulations, supply continuity and protecting product stability and brand trust, positioning itself as a reliable partner amid sector disruption.
The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.
More about Clover Corporation Limited
Clover Corporation Limited is an Australian company listed on the ASX that focuses on forming strategic relationships in technology, new product development and commercialisation. Leveraging proprietary microencapsulation technology, it supplies high‑purity nutritional oils, including tuna, fish, algal and fungal oils, for use in infant formula, foods and beverages, protecting these sensitive ingredients from oxidation and enabling their incorporation into a wide range of applications.
Average Trading Volume: 141,178
Technical Sentiment Signal: Hold
Current Market Cap: A$131.1M
For a thorough assessment of CLV stock, go to TipRanks’ Stock Analysis page.